Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Comment] Towards eradication of hepatitis C virus from dialysis units

Hepatitis C virus (HCV) infection is more common in patients with chronic kidney disease stage 4 or 5 than in the general population.1,2 HCV transmission might be either nosocomial within the dialysis unit, or from (mostly past) blood transfusions, or occasionally from an infected graft.2,3 HCV infection is a strong independent risk factor for death in patients on dialysis.4 With (peg)interferon and ribavirin, sustained viral response (SVR) rates are low, around 35% in dialysis patients, and tolerance is poor.